Effect of Osteopathic Manipulation on Circulating Immune Markers
A Molecular Approach to Examining the Immune Stimulatory Impact of Lymphatic Pump Technique in Healthy Patients; A Pilot Study
2 other identifiers
interventional
33
1 country
1
Brief Summary
The goal of this clinical trial is to learn if osteopathic manipulative treatment (OMT) changes levels of immune markers in healthy volunteers. The main questions it aims to answer are: Does OMT change numbers of white blood cells or antibodies? Does OMT change levels of cytokines? Researchers will compare volunteers treated with OMT to volunteers undergoing sham treatment to see if OMT changes levels of immune markers. Participants will:
- complete a survey about their medical history to determine if they are healthy enough for OMT
- have blood drawn
- undergo either sham treatment or OMT
- have blood drawn 30 minutes after treatment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 17, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 17, 2025
CompletedFirst Submitted
Initial submission to the registry
May 28, 2026
CompletedFirst Posted
Study publicly available on registry
June 3, 2026
CompletedJune 3, 2026
May 1, 2026
5 months
May 28, 2026
May 28, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Changes in Circulating Immune Markers
within 30 minutes of treatment
Study Arms (2)
Osteopathic Manipulative Treatment (OMT)
EXPERIMENTALSham Treatment
SHAM COMPARATORInterventions
Lymphatic Pump Techniques
Eligibility Criteria
You may qualify if:
- subjects are healthy; have independently read, understood, and without coercion signed the consent form; agree to allow for samples to be taken; agree to fill out all the documentation and surveys; and identifies as any race(s), ethnicity(ies), and/or gender(s)
You may not qualify if:
- subjects present at initial visit with a fever greater than 100.5 °F; have participated in a clinical trial within the last 6 months; work night shifts; who are immunocompromised including: HIV+, have had cancers, or are pregnant or nursing; have current bone fractures of the head and neck; history of osteoporosis, acute hepatitis, deep vein thrombosis, pulmonary embolism, trauma to the liver or spleen, surgery in the past 6 months or necrotizing fasciitis. Other relative contraindications to receiving OMT include doderate to severe cardiac conditions, moderate to severe congestive heart failure, infectious mononucleosis, chronic abscesses or osteomyelitis, coagulopathies or patients on anticoagulants, COPD, and acute indurated lymph node
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Edward Via College of Osteopathic Medicine
Monroe, Louisiana, 71203, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Discipline Chair for Immunology and Microbiology
Study Record Dates
First Submitted
May 28, 2026
First Posted
June 3, 2026
Study Start
January 10, 2025
Primary Completion
June 17, 2025
Study Completion
June 17, 2025
Last Updated
June 3, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
IPD sharing was not part of patients informed consent